Hypertension in dialysis patients

Mineral and Electrolyte Metabolism

Volumn 25, Issue 1-2, 1999, Pages 84-89

  Bellinghieri, Guido ^a   Santoro, Domenico ^b   Mazzaglia, Giampiero ^b   Savica, Vincenzo ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b NONE

Author keywords

Angiotensin converting enzyme inhibitors; Dialysis; Hypertension; Pathogenesis; Sicilian data

Indexed keywords

ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN; ERYTHROPOIETIN; KININ; NITROUS OXIDE; POLYACRYLONITRILE; PROSTAGLANDIN; VASOPRESSIN;

ADRENERGIC SYSTEM; ANTIHYPERTENSIVE THERAPY; ARTICLE; AUTONOMIC DYSFUNCTION; DIALYSIS; HUMAN; HYPERTENSION; HYPERVOLEMIA; PATHOGENESIS; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL;

BLOOD VOLUME; HUMANS; HYPERTENSION; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PREVALENCE; RENAL DIALYSIS;

EID: 0032916984     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057426     Document Type: Article

References (32)

1. Degoulet P, Legrain M, Roach I, Aime F, Devreis C, Rojas P, Jacobs C: Mortality risk factors in patients treated by chronic hemodialysis. Nephron 1982;31:103-110.
2. Quarello F, Piccoli, GB, Magistroni P, et al: Arterial hypertension and mortality in dialysis patients: in Zoccali C (ed): Clinical Hypertension in Nephrology. Contrib Nephrol. Basel, Karger, 1996, vol 119, pp 141-146.
3. Blythe WB: Natural history of hypertension in renal parenchymal disease. Am J Kidney Dis 1985;5:A50.
4. Charra B: Control of blood pressure in long slow haemodialysis. Blood Purif 1994;18:252-258.
5. White RP, Rubin AL: Blood pressure control in chronic dialysis patients: in Drukkcr W, Parsons FM, Maher JF (eds): Replacement of Renal Function by Dialysis. Boston, Martinus Nijhoff, 1993, p 575.
6. Raine AEG, Margreiter R, Brunner FP, et al: Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 1992;7(suppl 2):7-35.
7. Ritz E, Koch M: Morbidity and mortality duc to hypertension in patients with renal failure. Am J Kidney Dis 1993;21(suppl 2):113-118.
8. London GM, Marchais SJ, Safar ME, Genest AF, Guerin AP, Metivier F: Aortic and large artery compliance in end-stage renal failure. Kidney Int 1990;37:137-142.
9. Velasquez MT, Lew SQ, Von Albertin B, Mishkin GJ, Bosch JP: Control of hypertension is better during hemodialysis than during continuous ambulatory peritoneal dialysis in ESRD patients. Clin Nephrol 1997;48:341-345.
10. Hamburger RJ, Christ PG, Morris PA, Luft FC: Does CAPD provide an advantage? Adv Perit Dial 1989;5:91.
11. Enia G: Impact of hypertension in CAPD patients; in Zoccali C (ed): Clinical Hypertension in Nephrology. Contrib Nephrol. Basel, Karger, 1996, vol 119, pp 147-151.
12. Parfrey PS, Harnett JD, Griffiths SM, Gault MH, Barre P: Congestive heart failure in dialysis patients. Arch Intern Med 1988;148:1519.
13. London GM, Fabiani F: Left ventricular dysfunction in end stage renal disease: Echocardiografic insights: in Parfrey PS, Harnett JD (eds): Cardiac Dysfunction in Chronic Uraemia. Boston, Kluwer Academic, 1991, p 17.
14. Vincenti F, Amend WJ, Abele J, Feduska NJ, Salvaticrra O: The role of hypertension in haemodialysis-associated atherosclerosis. Am J Med 1980;68:363.
15. Ludens JH, Clark MA, DuCharme DW, Harris DW, Lutzke BS, Mandel F, et al: Purification of an endogenous digitalis-like factor from human plasma for structural analysis. Hypertension 1991;17:923-929.
16. + exchange/hypertension hypothesis. Am J Med 1984;99:604.
17. Salvetti A, Bozzo MV, Graziola M, Abdel-Haq B: Acute hemodynamic effect of nifedipine in hypertension with chronic renal failure: The influence of volume status. J Cardiovasc Pharmacol 1987;10(suppl 10):143.
18. Raine AEG, Bedford L, Simpson AWM, Ahhley CC, Brown R, Woodhead JS, Ledingham JGG: Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure. Kidney Int 1993;43:700.
19. Guerin AP, London GM, Marchais SJ, Metivier F, Safar ME, Sassano P: Parathyroid hormone and cardiovascular effects of dihydropyridines in chronic renal failure. Am J Hypertens 1990; 3:566.
20. Safar ME, London GM, Weiss YA, Milliez PL: Overhydration and renin in hypertensive patients with terminal renal failure: A hemodynamic study. Clin Nephrol 1975;5:183.
21. Weidmann P, Beretta-Piccoli C, Steffen F, Blumberg A, Reubi FC: Hypertension in terminal renal failure. Kidney Int 1976;9:294.
22. Fadem SZ, Lifschitz MD: Use of saralasin in end stage renal disease. Kidney Int 1979; 15(suppl):93.
23. Dzau VJ: Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med 1993;153:937.
24. Schohn D, Weimann P, Jahn H, Beretta-Piccoli C: Norepinephrin-related mechanism in hypertension accompanying renal failure. Kidney Int 1985;28:814-822.
25. Converse RL, Jacobsen TN, Toto RD, Jost JMC, Cosentino F, Fouad-Tarazi F, Victro RG: Sympathetic overactivity in patients with CRF. N Engl J Med 1992;327:1912-1918.
26. Bigazzi R, Kosogov E, Campese VM: Altered norepinephrine turnover in the brains of rats with chronic renal failure. J Am Soc Nephrol 1994;4:1901-1907.
27. Campese V, Kojosov E: Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension 1995;25:878-882.
28. Iseki K, Massry SG, Campese VM: Evidence for a role of PTH in the reduced pressor response to norepinephrine in chronic renal failure. Kidney Int 1985;28:12.
29. Vallance P, Leone A, Calver A, Collier J, Moncada S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992;339:572-575.
30. Kooman JP, Gladziwa U, Bocker G, Wijnen JAG, et al: Blood pressure during the interdialytic period in haemodialysis patient: Estimation of representative blood pressure values. Nephrol Dial Transplant 1992;7:917-923.
31. Nonnast-Daniel B, Creutzig A, Kühn K, Bahlmann J, Reimers E, Brunkhorst R, et al: Effect of treatment with human erythropoietin on peripheral hemodynamics and oxygenation; in Koch KM, Kühn K, Nonnast-Daniel B, Scigalla P (eds): Treatment of Renal Anemia with Recombinant Human Erythropoietin. Contrib Nephrol. Basel, Karger, 1988, vol 66, p 185.
32. Tielemans C, Madhoun P, Lenaers M, Schandene L, Goldman M, Vanherweghem JL: Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors. Kidney Int 1990;38:982-984.